Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma
Clinical trial NCT03259425 · TERMINATED
Trial details
- NCT number
- NCT03259425
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-03
- Primary completion
- 2018-09-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.